智通财经APP讯,再鼎医药(09688)发布公告,于2025年4月22日因兑现按先前披露的条款(1)归属根据 2017,2022及2024年股权激励计划所授出的非期权奖励,及(2)如适用,行使根据2015,2017,2022及2024年股权激励计划所授出的购股权发行新股200万股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.